Avalo Therapeutics (AVTX) Asset Utilization Ratio (2016 - 2025)
Avalo Therapeutics (AVTX) posted Asset Utilization Ratio of 0.0 for Q4 2025, up 18.13% on a QoQ basis from 0.0 in Q3 2025, and up 16.96% year-over-year from 0.0 in Q4 2024.
Avalo Therapeutics (AVTX) Asset Utilization Ratio (2016 - 2025) Analysis & Trends
Avalo Therapeutics' Asset Utilization Ratio history runs 10 years deep, the most recent figure standing at 0.0 for Q4 2025.
- Quarterly Asset Utilization Ratio rose 16.96% year-over-year to 0.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.0 (up 16.96% YoY) and the FY2025 annual result came in at 0.0, down 91.4% from the prior year.
- Asset Utilization Ratio was 0.0 for Q4 2025 at Avalo Therapeutics, up from 0.0 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.56 in Q2 2023 and bottomed at 0.0 in Q3 2025.
- A 5-year average of 0.15 and a median of 0.08 in 2022 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio jumped 739.91% — and 2024, when it sank 98.76%.
- Avalo Therapeutics' Asset Utilization Ratio stood at 0.06 in 2021, then surged by 739.91% to 0.52 in 2022, then sank by 85.17% to 0.08 in 2023, then plunged by 95.38% to 0.0 in 2024, then rose by 16.96% to 0.0 in 2025.
- Business Quant data shows AVTX's Asset Utilization Ratio at 0.0 in Q4 2025, 0.0 in Q3 2025, and 0.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Avalo Therapeutics | 1.04 Mn | 1.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.01 |
| Mar 31, 2024 | 0.02 |
| Dec 31, 2023 | 0.08 |
| Sep 30, 2023 | 0.08 |
| Jun 30, 2023 | 0.56 |
| Mar 31, 2023 | 0.50 |
| Dec 31, 2022 | 0.52 |
| Sep 30, 2022 | 0.51 |
| Jun 30, 2022 | 0.08 |
| Mar 31, 2022 | 0.09 |
| Dec 31, 2021 | 0.06 |
| Sep 30, 2021 | 0.08 |
| Jun 30, 2021 | 0.10 |
| Mar 31, 2021 | 0.08 |
| Dec 31, 2020 | 0.13 |
| Sep 30, 2020 | 0.14 |